AVXL HAS RELEASED TRIAL RESULTS FOR A TOTAL OF 38 PATIENTS WORLD WIDE YET A2-73 AND THE REST OF AVXL'S PIPELINE IS NOT APPROVED!!!!!!
ONLY LOGIC REASON TO EXPLAIN THE ABOVE:
THERE IS A GLOBAL CONSPIRACY BY THE FDA, EMA, TGA, BP AND THE REST OF THE CABAL TO KEEP A2-73 AND THE REST OF AVXL'S PIPELINE FROM THE SICK!!!!!!!!!!
Wrong! There are many biotech companies that jump with results and hold their value and some even get bought pre-revenue. So, market does value pre-revenue companies.
Wrong! There are many biotech companies that jump with results and hold their value and some even get bought pre-revenue. So, market does value pre-revenue companies.
You are right there have been others (thats not what I meant) I meant just so far not Anavex and as it's going now I don't see that change even after wonderful readout this sumer. After readout june-sept Anvavex should, like those other biotechs really start to connect with Wall Street.